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A B S T R A C T
Real-time functional magnetic resonance imaging (fMRI) neurofeedback training of amygdala hemodynamic
activity directly targets a neurobiological mechanism, which contributes to emotion regulation problems in
borderline personality disorder (BPD). However, it remains unknown which outcome measures can assess
changes in emotion regulation and affective instability, associated with amygdala downregulation in a clinical
trial. The current study directly addresses this question. Twenty-four female patients with a DSM-IV BPD di-
agnosis underwent four runs of amygdala neurofeedback. Before and after the training, as well as at a six-weeks
follow-up assessment, participants completed measures of emotion dysregulation and affective instability at
diverse levels of analysis (verbal report, clinical interview, ecological momentary assessment, emotion-modu-
lated startle, heart rate variability, and fMRI). Participants were able to downregulate their amygdala blood
oxygen-dependent (BOLD) response with neurofeedback. There was a decrease of BPD symptoms as assessed
with the Zanarini rating scale for BPD (ZAN-BPD) and a decrease in emotion-modulated startle to negative
pictures after training. Further explorative analyses suggest that patients indicated less affective instability, as
seen by lower hour-to-hour variability in negative affect and inner tension in daily life. If replicated by an
independent study, our results imply changes in emotion regulation and affective instability for several systems
levels, including behavior and verbal report. Conclusions are limited due to the lack of a control group. A
randomized controlled trial (RCT) will be needed to confirm effectiveness of the training.
1. Introduction
Emotion dysregulation is considered a hallmark of borderline per-
sonality disorder (BPD) (Glenn and Klonsky, 2009; Sanislow et al.,
2002; Schmahl et al., 2014), characterized by heightened reactivity to
negative stimuli, with impairments in the implementation and main-
tenance of adaptive and appropriate emotion regulation strategies, as
well as heightened experience of negative affect (Carpenter and
Trull, 2013). On a neural level, a key feature of BPD is hyperactivation
of the amygdala in response to negative and neutral stimuli (Schulze
et al., 2019), likely reflecting the emotion dysregulation observed in
BPD patients (Schmahl et al., 2014).
Current emotion regulation models implicate downregulation of the
amygdala as a mechanism to control emotions in clinical contexts
(Buhle et al., 2014; Etkin et al., 2015). A normalization of amygdala
activation and improved emotion regulation were found during Dia-
lectical Behavior Therapy (DBT) in BPD patients, suggesting that
amygdala response is an important indicator of BPD remission
(Goodman et al., 2014; Schmitt et al., 2016). However, it is not clear
whether decreased amygdala response mediates BPD remission. Until
recently, probing this has been virtually impossible, as techniques to
tackle subcortical activation were limited to highly invasive deep-brain
stimulation.
With the emergence of real-time functional magnetic resonance
imaging (fMRI), modulation of emotion brain circuitry became feasible
(Linhartová et al., 2019). With feedback from brain activation in real-
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time, dubbed neurofeedback, healthy subjects (Brühl et al., 2014;
Herwig et al., 2019; Keynan et al., 2016; Paret et al., 2014) and patients
(Nicholson et al., 2017; Paret et al., 2016) were able to reduce their
amygdala activation during real-time fMRI. The benefits of this new
technique are two-fold: first, assessing behavioral sequels of neuromo-
dulation provide a better understanding of mechanisms that contribute
to reduced amygdala activation in BPD. Second, the potential to address
dysregulated neurobiological mechanisms with neurofeedback could be
used for BPD treatment. However, before addressing these goals, pri-
mary outcome measures for clinical trials must be identified.
Emotion dysregulation in BPD has been studied with a plethora of
measures, such as emotional picture-viewing tasks (Krause-Utz et al.,
2012), clinical interviews (Zanarini et al., 2003), retrospective ques-
tionnaires (Glenn and Klonsky, 2009; Gratz et al., 2006; Salsman and
Linehan, 2012) and affective variability in ecological momentary as-
sessment (EMA) (Ebner-Priemer et al., 2007; Nica and Links, 2009;
Santangelo et al., 2017). In addition, psychophysiological indices such
as resting heart rate variability (HRV) and startle modulation have been
used to study emotion dysregulation in BPD (Ebner-Priemer et al.,
2005; Thompson et al., 2018). BPD patients show lower resting HRV
than controls (Koenig et al., 2016), which is indicative of less regulation
ability (Appelhans and Luecken, 2010). Cognitive emotion regulation
diminishes emotion-modulated startle in healthy individuals (Jackson
et al., 2000; Zaehringer et al., 2018) and BPD patients (Thompson et al.,
2018), as this downregulation correlates with downregulation of af-
fective states (Zaehringer et al., 2018). Similarly, studies report asso-
ciations of amygdala hyperactivation and BPD diagnosis (Schulze et al.,
2019), outlining a pathway of amygdala regulation via self-injury
(Reitz et al., 2015), and reporting a coincidence of amygdala normal-
ization with response to psychotherapy (Goodman et al., 2014). Yet,
little action has been shown to map amygdala hyperactivation with
behavioral correlates of emotion dysregulation and affective instability.
It is unknown what aspects of BPD symptomatology improve with
normalization of amygdala activation. Thus, evidence is very limited,
impeding informed selection of a primary outcome measure for clinical
trials that assess amygdala neuromodulation. The present study ad-
dressed exactly this question, i.e., what aspects of emotion dysregula-
tion improve following amygdala neurofeedback? Moreover, because
dysfunction of emotion neurocircuitry manifests through dysregulated
behavior, including the verbal report of symptoms collected in standard
psychometric assessments (LeDoux and Pine, 2016), we used a multi-
modal assessment of psychopathology, explained below. BPD patients
underwent four sessions of neurofeedback training and received a test
battery directly before training, both after training and at 6-weeks
follow-up. The test battery included a multimodal assessment of emo-
tion regulation of self-report, EMA, behavioral, and fMRI measures. We
hypothesized that BPD patients would downregulate the amygdala with
neurofeedback. In addition, we hypothesized that BPD patients would
show significant changes at several system levels, i.e., verbal report,
everyday experience, and behavior and brain responses. Specifically,
we hypothesized reductions in emotion dysregulation and improved
clinical symptoms, enhanced emotion regulation as shown by increased
resting HRV, improved emotion regulation in an established laboratory
task (Jackson et al., 2000), and decreased amygdala response to emo-
tional pictures. In addition, we explored changes in everyday experi-
ence as well as changes in a number of aspects of emotion regulation
and BPD psychopathology.
2. Methods and materials
2.1. Participants
Twenty-six female patients with at least 5 BPD criteria, according to
the DSM-IV (American Psychiatric Association, 2000) participated in
the present study. All participants were on stable medication (see
Table 1 for details on medication) during the course of the study. In
case participants receiving psychotherapeutic treatment, they were re-
quired to maintain it throughout the study. Two patients were excluded
after completion (one patient reported amphetamine consumption
during participation, and one patient fell asleep during the neurofeed-
back runs).
The diagnostic assessment comprised the Structured Interview for
DSM-IV Axis-I (First et al., 1997) and the International Personality
Disorder Examination (Loranger, 1999). Patients were excluded from
our study in cases of severe somatic illness and if exclusion criteria
related to MRI were fulfilled (metal implants, left-handedness, claus-
trophobia, and pregnancy). Further exclusion criteria were alcohol or
substance abuse within the last 6 months, lifetime psychotic disorder,
bipolar affective disorder, or mental retardation.
A total of n= 108 individuals were initially screened for our study.
N = 77 had to be excluded because they did not fulfill our inclusion
criteria, were not interested in the first place or were interested but
ultimately did not participate. Thus n=31 participants were allocated
to our study and n=26 of them received the full neurofeedback
training. A detailed flow chart of the study is shown in Fig. S1 in the
supplement.
Descriptive statistics of demographic variables are reported in
Table 1. The study was approved by the Ethics Committee of the
Medical Faculty Mannheim / Heidelberg University and was conducted
according to the Declaration of Helsinki. All subjects gave written in-
formed consent prior to participation and received financial compen-
sation (120 Euros). The research protocol was registered on Clinical-
Trials.gov (NCT02866110) and the Deutsches Register für Klinische
Studien (drks.de; DRKS00009363).
2.2. Procedure
Participants took part in four runs of amygdala neurofeedback
training. Runs were administered on 3 different days, with run 2 and 3
being administered consecutively on the second training day. Training
days were scheduled 2–7 days apart from each other. At baseline (T0)
and after completion of amygdala neurofeedback training (T1), the test
battery was administered. All measures except EMA were assessed
again at 6-weeks follow-up (T2). For details of the procedure, see Fig. 1.
The consensus on the reporting and experimental design of clinical and
cognitive-behavioral neurofeedback studies (CRED-nf checklist




Subjects were instructed to look at negative pictures (without
feedback, ‘view’ condition), or downregulate a colored thermometer
bar, representing brain activation while watching negative pictures
(‘down’ condition), respectively. Participants were not given a parti-
cular strategy to downregulate. Rather, they were told to assess what
strategy worked best for them. In the ‘view’ condition, a picture with
negative emotional content was presented for 18 s, followed by a
fixation cross on a grey background (‘rest,’ 12 s). In the ‘down’ condi-
tion, pictures were presented with feedback. After each neurofeedback
session, participants were asked which strategies they used to down-
regulate (s. supplement for details). For details, see Fig. 2. Three par-
ticipants had to be excluded from the statistical analysis due to tech-
nical problems in session 2 and 4 (logfiles were not available).
2.3.2. Online fMRI data analysis
The neurofeedback signal was computed as the fMRI percent of
signal change, relative to the global mean, and updated every second
and displayed as a colored bar. The BOLD signal data were calculated
online from voxels within a right amygdala mask, produced with the
Harvard-Oxford brain atlas with a probability threshold of 25%. Details
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Table 1
Means (SD) of demographics, clinical characteristics and questionnaire data
T0 T1 T2 Test-Statistics
F df p
Demographics
Age mean (SD) 33.42 (11.10)
Clinical Characteristics
Number of BPD criteria fulfilled (DSM-V) 6.61 (1.03)
Borderline Symptoms ZAN-BPD
Total (SD) 7.48 (3.88) 5.09 (3.99) 5.55 (3.33) 5.13 2, 46 .01 T0 > T1
Affect (SD) 2.9 (1.36) 2.09 (1.41) 2.30 (1.25) 3.43 2, 46 .04 T0 > T1
Cognition (SD) 2.17 (1.74) 1.35 (1.46) 1.25 (1.17) 4.52 2, 46 .02 T1 > T2
Impulsivity (SD) 0.96 (1.46) 0.96 (1.43) 0.85 (0.80) 0.11 1.57, 36.14 .85
Interpersonal Relationships (SD) 1.48 (1.13) 0.96 (1.30) 1.15 (1.51) 3.82 2, 46 .03 T0 > T1
Difficulties with Emotion Regulation Scale (DERS)
Total (SD) 123.29 (17.49) 121.71 (18.73) 113.20 (20.88) 3.80 2, 46 .03
Nonaccepatence (SD) 20.79 (5.32) 21.62 (5.56) 19.45 (4.33) 2.08 2, 46 .14
Goals (SD) 20.08 (3.37) 19.25 (3.76) 18.44 (3.72) 3.70 2, 46 .03 T0 > T2
Impulse (SD) 18.21 (4.01) 17.63 (3.77) 16.96 (4.18) 1.02 2, 46 .37
Awareness (SD) 20.21 (5.30) 19.75 (5.75) 18.79 (5.38) 3.18 2, 46 .05
Strategies (SD) 28.79 (4.73) 28.58 (.,52) 25.86 (5.98) 4.52 2, 46 .02 T0 > T2,T1 > T2
Clarity (SD) 15.21 (4.18) 14.88 (3.95) 13.69 (3.76) 1.99 2, 46 .25
Affect Lability Scale (ALS)
Total (SD) 89.42 (16.86) 92.89 (17.56) 88.98 (18.66) 0,45 2, 46 .64
Depression 17.33 (4.53) 18.76 (4.31) 19.18 (3.88) 1.37 2, 46 .26
Elation 20.04 (5.69) 18.98 (6.11) 18.65 (6.68) .48 2, 46 .62
Depression Elation 13.88 (4.06) 14.51 (4.51) 14.89 (4.34) .45 2, 46 .67
Anxiety 12.17 (2.53) 13.90 (3.51) 12.25 (3.62) 2.41 2, 46 .10
Anger 12.63 (2.60) 12.10 (3.26) 10.89 (3.43) 2.28 2, 46 .11
Anxiety Depression 13.38 (3.66) 14.59 (4.08) 13.12 (4.40) 0.90 2, 46 .40
Toronto Alexithymia Scale (TAS-26)
Total (SD) 54.17 (10.29) 53.50 (9.56) 50.54 (10.78) 2.76 1.36, 31.22 .096
Identification of one's feelings 22.67 (4.05) 21.29 (3.98) 19.82 (4.84) 6.25 2, 46 .004 T0 > T2
Difficulty Describing Feelings 15.96 (3.61) 16.58 (3.93) 15.39 (3.83) 1.39 2, 46 .26
External thinking 15.54 (4.81) 15.63 (4.99) 15.33 (4.97) 0.05 1.47, 33.72 .95
Emotion Regulation Skills Questionnaire
Total (SD) 78.61 (21.31) 77.87 (20.27) 86.83 (18.26) 5.90 2, 46 .01 T0 < T2
Awareness 9 (3.24) 9.71 (3.45) 10.27 (2.90) 3.85 2, 46 .03 T1 < T2
Clarity 9 (2.47) 9.00 (2.96) 9.63 (2.49) 4.65 10.31, 2.22 .03 T0 < T2
Sensations 8.58 (2.98) 8.25 (2.94) 10.33 (2.63) 4.08 2, 46 .02 T0 < T2
Understanding 9.33 (3.23) 8.71 (3.16) 9.73 (2.43) 4.64 2, 46 .02 T1 < T2
Accepatnce 8.5 (2.87) 8.37 (2.39) 8.59 (2.76) 5.96 2, 46 .01 T1 < T2
Tolerance 8.06 (2.86) 7.83 (2.55) 9.77 (2.86) 0.90 2, 46 .41 T1 < T2
Readiness to confront distressing situations 9.58 (3.12) 9.25 (3.30) 9.45 (2.71) 0.17 2, 46 .84
Self-support 8.75 (2.79) 8.79 (2.70) 9.77 (2.85) 3.62 2, 46 .04
Modification 7.79 (2.77) 7.96 (2.74) 8.91 (2.26) 2.88 2, 46 .07
UPPS
Urgency (SD) 2.9 (0.46) – – – –
Pre (SD) 2.37 (0.45) – – – –
Pers (SD) 2.54 (0.51) – – – –
SS (SD) 2.76 (0.54) – – – –
DSS-21
Intensity (SD) 18.49 (11.65) 14.80 (9.42) 14.48 (10.43) 2.16 1.36, 31.32 .12
Duration (SD) 18.49 (1.28) 2.24 (1.42) 2.18 (1.36) 1.47 1.23, 35.41 .24
Current comorbidities N (%)
Major Depression 6 (24%)
Major Depression lifetime 22 (88%)
Dysthymia 4 (16%)
Double Depression 3 (12%)
Panic Disorder 3 (12%)
Social Phobia Disorder 4 (16%)
Specific Phobia 5 (20%)
PTBS 6 (24%)
Anorexia Nervosa 1 (4%)
Bulimia Nervosa 1 (4%)
Binge Eating Disorder 2 (8%)








Notes: SD, standard deviation; UPPS, Impulsive Behavior Scale; DSS-21, Dissociation Tension Scale; SSRI, Selective serotonin reuptake inhibitor; SNRI,
Serotonin–norepinephrine reuptake inhibitor.
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of fMRI acquisition, real-time fMRI analysis, and feedback presentation
are in the supplement, and were published by Paret et al. (2018).
2.4. Assessments
2.4.1. Verbal report: Interviewer- and self-assessment
Self-assessment included several questionnaires on different aspects
of BPD psychopathology and emotion regulation.
To test our hypothesis on changes in emotion dysregulation, we
used the difficulties with the Emotion Regulation Scale (DERS; Gratz
and Roemer, 2004), a 36-item questionnaire that assesses levels of
emotion regulation problems. The DERS is comprised of six subscales
(nonacceptance of emotional response difficulties in engaging in goal-
directed behavior, impulse control difficulties, lack of emotional
awareness, limited access to emotion regulation strategies, and lack of
emotional clarity). The DERS was found to have adequate construct and
predictive validity and good test-retest reliability over a period of 4–8
weeks (ρI= .88; Gratz and Roemer, 2004).
To test our hypothesis on changes in clinical status, we assessed the
Zanarini rating scale for BPD (ZAN-BPD; Zanarini et al., 2003). The
ZAN-BPD is a semi-structured interview and reflects a 1-week time
frame. The nine criteria for BPD were rated on a five-point anchored
rating scale of 0–4 by trained psychologists (JZ, CP, SM), yielding a
total score between 0 and 36. The ZAN-BPD demonstrates good relia-
bility (Cronbach's alpha= 0.85), with convergent and discriminant
validity (Zanarini et al., 2003). One participant was excluded for the
statistical analysis of the ZAN-BPD, because she did not do the inter-
view at T2.
In addition to these two measures, we assessed several other ques-
tionnaires which were used for explorative analyses: The German ver-
sion of the Emotion Regulation Skills Questionnaire (SEK-27; Berking
and Znoj, 2008; Grant et al., 2018) was used to assess emotion reg-
ulation skills. The SEK-27 is a 27-item self-report instrument that uti-
lizes a 5-point Likert-type scale (0=not at all to 4= almost always) to
assess the respondent's adaptive emotion regulation skills the previous
week. The SEK-27 comprises six subscales: (1) awareness, (2) clarity,
(3) understanding, (4) modification, (5) acceptance, and (6) tolerance.
In addition to the subscales, the SEK-27 provides a total score, com-
puted as the average of all items. The SEK-27 showed adequate internal
consistency (Cronbach's alpha= .90 for the total score, and .68–.81 for
subscales), as well as adequate test-retest reliability (r= .75 for total
score). The Affective Lability Scale (ALS; Harvey et al., 1989), a 54-item
Fig. 1. Participants received a total of 4 runs
of amygdala neurofeedback training (weeks
2–3). Runs were administered on 3 different
days, with run 2 and 3 being administered
consecutively on the second training day. At
baseline (T0), participants completed an emo-
tion test battery: ecological momentary as-
sessment (EMA) was assessed on 4 consecutive
weekdays before neurofeedback started (week
1). At the beginning of week 2, the Zanarini
Rating Interview (ZAN-BPD), self-report ques-
tionnaires, heart rate variability (HRV), and an emotion regulation task with emotion-modulated startle (Startle) was administered. Participants also answered an
Emotional Working Memory Task (EWMT) and a Backward Masking Task (BMT) during fMRI, immediately before completion of the first neurofeedback session.
From 2 to 7 days later, participants completed the next neurofeedback session (visit 2), followed by 2–7 days for their third and final session (visit 3). During these
sessions, participants were instructed to downregulate a thermometer, with activity of the right amygdala, while watching aversive pictures. Details of the neu-
rofeedback procedure can be found in the supplement. Immediately after the last neurofeedback session (end of week 3), the test battery was administered a second
time (T1). The follow-up visit (T2) was completed 6 weeks after visit 3, and was identical to T1, excluding EMA (week 8).
Fig. 2. Experimental procedure of a neurofeedback training run. Participants viewed aversive pictures, with a feedback signal from their amygdala BOLD response,
which is depicted as a thermometer. They were instructed to try to downregulate the temperature, representing their brain activation. They were also told to consider
the temporal delay of the BOLD response, resulting in a time lag of the thermometer response (2–5 s). Furthermore, they should not close their eyes or shift their gaze
from the screen and avoid focusing exclusively on the thermometer or borders of the picture. They should not hold their breath or move their heads. After
participants entered the scanner, anatomical and fieldmap scans were acquired. Before the first neurofeedback run, a demonstration trial was presented without fMRI
scanning. Subjects were instructed beforehand to look at the picture (without feedback), or to downregulate the thermometer signal. The neurofeedback consisted of
‘down’ and ‘view’ conditions, respectively. In the ‘view’ condition, a picture with negative emotional content was shown for 18 s, followed by a fixation cross on a
grey background (‘rest,’ 12 s). In the ‘down’ condition, pictures were presented with feedback. Six pictures were presented in a ‘down’ block, each for 18 s (108 s
total). The order of conditions was fixed, with alternating ‘view’ and ‘down’ blocks. In total, there were 5 ‘down’ blocks and five ‘view’ blocks. After the last block,
participants were instructed to rate their perceived regulation success (‘Were you able to regulate the display?’) on a 10-level visual analogue scale (results can be
found in the supplement).
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self-report scale, was used to measure changeable affect. ALS items
assessed subjects’ perception of their tendency to vary between what
they considered a normal mood versus those of anger (ANG), depres-
sion (DEP), elation (ELA), and anxiety (ANX), with a tendency to os-
cillate between depression and elation (BIP), or between states of an-
xiety and depression (ANXDEP). Each item was rated on a four-point
scale (scored 0–3 inclusive) from ‘‘very undescriptive’’ to ‘‘very de-
scriptive’’ of themselves. The ALS total is the mean of six subscales for
individual affect shifts, and showed good internal consistency (among
subscales, alpha range= .76–.86). The Toronto Alexithymia Scale
(TAS-26; Bagby et al., 1994), a 26-item scale, was used to measure
alexithymia in three dimensions: difficulty identifying feelings, difficulty-
describing feelings, and externally-oriented thinking. The TAS-26 displays
adequate reliability, ranging from r= .67 to r= .84. We further used
the Dissociation Tension Scale (DSS; Stiglmayr et al., 2009) to assess
dissociative symptoms, with the short version of the UPPS Impulsive
Behavior Scale (Cyders et al., 2014) to control baseline impulsivity.
2.4.2. Everyday experience: EMA
To measure affective instability and emotion regulation during
participants’ everyday lives, we used a smartphone programmed with
the movisensXS app (Movisens GmbH, Karlsruhe, Germany) as an
electronic diary. The e-diary emitted a prompting signal according to a
stratified random schedule, with 12 assessments per day between
9:00 a.m. and 10:00 p.m. on four consecutive workdays. Thus, the 13-h
assessment period of each day was divided into 12 intervals, with as-
sessments scheduled at random within each one. At each prompt, we
assessed participants’ current affective state using five questions about
positive affect (PA) and five questions about negative affect (NA), based
on the affective circumplex model (Russell, 1980). To assess partici-
pants’ current dissociative state, we used the DSS-4, including an item
asking about aversive tension (5 items; (Stiglmayr et al., 2009). We also
assessed participants’ perceived control over their emotions with two
items (“When the phone rang, I felt like I could control my feelings” and
“When the phone rang, I felt overwhelmed by my feelings”). The
wording of all items can be found in the supplement. We determined
the person-mean of the repeated assessments, as well as the mean
squared for successive differences (MSSD) as an established instability
index for each person and for both assessment periods (i.e., for both the
pre- (T0) and post-(T1) neurofeedback training EMA assessment).
2.4.3. Behavior and peripheral physiology: Emotion regulation test, resting
HRV
To test changes in emotion regulation, we assessed the emotion-
modulated startle during an emotion regulation paradigm, modified
from Jackson et al. (2000). For details of the procedure, see Fig. 3A. In
brief, participants were instructed to view negative or neutral pictures
(‘view,’ ‘neutral’ condition) or to downregulate emotions in response to
negative pictures (‘down’ condition). Seven seconds into the regulation
phase, a burst of white noise was presented for 50 ms at 104 dB1 (startle
probe). The eye blink was measured by electromyogram (EMG). The
raw EMG signal was sampled at 1000 Hz, and the gain was amplified by
2000. High-pass (50 Hz) and low-pass (500 Hz) online filters were
applied to the data with AcqKnowledge software (version 3.4; BIOPAC
Systems; Goleta, CA, USA). EMG data were integrated over 10 samples
and analyzed offline with Clip, a C++ based, semi-automated program
(Kinzig et al., 2008). Emotion-modulated startle response was defined
as the difference between peak (20–120 ms after stimulus onset) and
baseline (20 ms prior to stimulus onset) signal. Amplitudes were
transformed to T-scores with mean=50 and SD=10. Responses were
averaged in participants for each condition. Emotion-modulated startle
amplitudes in the ‘neutral’ condition were subtracted from the ‘down’
and the ‘view’ conditions for statistical comparison. Four participants
(N=4) were excluded for statistical analysis of the startle data due to
technical problems at T0 or T1 (N=2). One participant did not show a
startle response at all and one participant did not complete the psy-
chophysiological tests at T2.
To test changes in resting HRV, we recorded the electrocardiogram
(ECG) for 6 min at 1000 Hz, with a gain of 2000. High-pass (50 Hz) and
low-pass (500 Hz) online filters were applied to the data with
AcqKnowledge software. Offline, ECG waveforms were transformed
into the heart rate (beats per minute) and analyzed with Kubios soft-
ware (Amsterdam, The Netherlands) (Tarvainen et al., 2014). Resting
HRV was calculated as the ratio of low frequency (LF) power in the
.04–0.15 Hz range and high frequency (HF) power in the 0.15–0.40 Hz
range, indicative of sympathetic to parasympathetic autonomic balance
(HF/LF). Three participants (N=3) were excluded: two (N = 2) were
excluded due to technical problems at T0 or T1, and one (N=1) did
not complete the psychophysiological tests at T2.
2.4.4. Brain responses
To test changes in amygdala response during shortly presented
pictures, we conducted the EWMT and the BMT in the fMRI. Details of
these procedures can be found in Fig. 3B and C. Three participants
(N=3) were excluded for the statistical analysis of the EWMT, due to
missing button presses all three times (n=2), and technical problems
at T1 (N=1; logfile not available). One participant was excluded for
the statistical analysis of the BMT due to technical problems at T1
(logfile not available).
2.5. Offline fMRI data analysis
2.5.1. Neurofeedback data
2.5.1.1. Preprocessing. Data analysis was performed with Matlab
(vR2012a)-based SPM12 package (v6225, Wellcome Trust Center for
Neuroimaging, London, UK). Preprocessing included slice timing,
which was corrected with reference to the middle slice of a volume,
realignment of the scans to the first scan of the series, with rigid body
transformation and correction of geometric distortions using a voxel
displacement map (VDM); this was produced based on fieldmap scans.
The functional scans were not warped, given the VDM parameters and
corrected for susceptibility-by-movement artifacts (Andersson et al.,
2001). A mean image of the functional scans was next computed and
coregistered to the anatomical scan of the subject; this scan was
segmented with six standard SPM tissue probability maps and
normalized to MNI space. These parameters were used for
normalization of functional images. Images were resampled to 2 mm
isometric voxels. Functional data were smoothed using an 8 mm kernel
(full width at half maximum, FWHM) to account for between-subject
variation in anatomical localization. Finally, a high-pass filter (256 s
cut-off) was added to the general linear model (GLM) to remove slow
signal drifts. An autoregressive model was used to account for serial
correlations.
2.5.1.2. Amygdala ROI (Region of Interest) analysis. We estimated HRFs
using the inverse logit model by Lindquist et al. (2009) to investigate
the hemodynamic amygdala response. First, the eigenvariate was
extracted from voxels corresponding to the right amygdala, with the
same mask being used for neurofeedback. The eigenvariate was also
adjusted for condition effects (‘down’ and ‘view’). HRFs were fitted to
each picture presentation interval. The HRF amplitude represents the
magnitude of the event-related BOLD response. In addition, we
analyzed the area under the curve (AUC). Amplitude estimates and
AUC values were compared with SPSS statistics software (v23, IBM
Corp. Armonk, NY, USA).
1 104 dB startle probes elicited severe discomfort in two participants.
Therefore, we turned down the volume to 95 dB for them. We reran startle
analyses without the two participants, without the results changing. Thus, we
report data from all participants.
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2.5.1.3. Amygdala down-regulation success. We quantified down-
regulation success by creating two different indices: First deltas of
amygdala amplitudes/AUCs (‘view’ minus ‘down’) between the first and
last neurofeedback run were created. However, as this index assumes
linear improvement and may misrepresent actual learning slopes, we
complemented this by calculating the best performance (Paret et al.,
2019) of each participant. That is, we determined the largest delta
between the ‘view’ and ‘down’ condition for each participant across all
four neurofeedback runs.
2.5.2. EWMT and BMT
2.5.2.1. fMRI data acquisition and analysis. For fMRI acquisition, a 3
Tesla MRI Scanner (Trio, Siemens Medical Solutions, Erlangen,
Germany) with a 32-channel head coil was used. T1-weighted
anatomical images were acquired with a Magnetization Prepared
Rapid Acquisition Gradient Echo sequence (TE = 3.03 ms,
TR = 2.3 s, 192 slices and FOV = 256 × 256 mm). Functional
images of both EWMT and BMT tasks were acquired with a gradient
echo T2* weighted echo-planar-imaging (EPI) sequence with a field of
view=210 mm×210 mm, voxel size= 3 mm×3 mm×3 mm, echo
time=30 ms, TR=2000 ms with 40 contiguous 3 mm sagittal slices in
a 64× 64 matrix. Head movement artifacts and scanning noise were
reduced with head cushions and headphones in the scanner coil.
Preprocessing was comprised of adjusting for variable acquisition
time over slices (slice-timing), head motion correction (realignment),
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Fig. 3. A) Experimental procedure of the
emotion regulation task. Participants
were instructed either to view negative
and neutral pictures without modifying
their emotions (‘view’; ‘neutral’ condi-
tion, respectively) or to downregulate
their feelings toward negative pictures
(‘down’ condition). Each trial began with
a 2000 ms presentation of an instruc-
tional cue (‘view’, ‘down’), followed by a
fixation cross displayed for 1000 ms.
Next, a neutral or negative picture was
presented for 10,000 ms. A startle probe
(50 ms, 95 dB white noise burst) was
presented through headphones at
6500 ms–9500 ms into the regulation
phase). Self-assessment Manikins (SAM
Ratings; Bradley and Lang, 1994) were
presented after presentation of each pic-
ture. Participants rated a 1–9 Likert scale
on how positive / negative and aroused /
calm they felt at that moment. Lower
scores on the valence scale indicated that
they felt more positive; lower scores on
the arousal scale indicated that they felt
calmer. Intertrial intervals were jittered
between 3500 and 5500 ms. Details
about stimuli and the procedure can be
found in the supplement. B)
Experimental procedure of the Emotional
Working Memory Task (EWMT), which is
an adapted Sternberg item recognition
task (Sternberg, 1966), modified by Oei
and colleagues (Oei et al., 2009; Krause-
Utz et al., 2012). Each trial started with
the presentation of a set of three letters
(memoranda, 875–1375 ms). After a
delay phase of 1250–1750 ms, another
set of three letters appeared on the screen
(probe, 2000 ms). Next, a blank screen
appeared (intertrial interval,
550–1050 ms). Participants had to press
the left or right button to indicate whe-
ther they recognized one of the memor-
anda-letters in the probe. In half of the
trials, one of three memoranda was pre-
sent. During the delay interval, no dis-
tractor (i.e., a fixation cross; ‘cross’ con-
dition) or a distractor (i.e., an aversive
picture; ’negative’ condition) was pre-
sented. Details of stimuli and the procedure can be found in the supplement. C) Experimental Procedure of the Backward Masking Task (BMT). Participants were instructed
to identify photographs of faces expressing happy or fearful facial expressions. The BMT had a total of four conditions: happy or fearful facial expressions presented for
33 ms or 83 ms. A total of 4 blocks per condition were presented. Each block consisted of 8 consecutive pictures. Each block began with a fixation cross. Next, eight faces
were shown for 33 ms or 83 ms, preceded by a red rectangle on a grey background for 5100 ms and followed by a mask (scrambled face) for 4100 ms. Details of the stimuli,
procedure, and behavioral results are in the supplement.
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defined by the Montreal Neurological Institute (MNI), and spatial
smoothing using an 8 mm Gaussian kernel to increase signal-to-noise
ratio.
2.5.2.2. First-level analysis. For the EWMT, we modeled regressors for
the memoranda, probe and response phase, respectively. In addition,
each condition was modeled (negative, cross). Parameter estimates
from the contrast of interest (negative > cross) were entered into
group-level t-tests. For the BMT, we modeled regressors for each
condition (happy faces 33 ms, happy faces 83 ms, fearful faces 33 ms,
and fearful faces 83 ms). All regressors were convolved with the HRF
implemented in SPM12. Parameter estimates from the contrast of
interest (all conditions versus implicit baseline) were entered into
group-level t-tests. To test our hypotheses, voxel-wise t-tests of
parameter estimates for the EWMT contrast negative > cross, and the
BMT contrast (all conditions versus implicit baseline) were conducted
on the first level. The mean contrast value was then extracted from all
voxels of the right amygdala, based on the neurofeedback mask.
2.6. Statistical analysis of assessments
Validated statistical software (SPSS v25; IBM Inc., Armonk, NY,
USA) was used for analyses. Missing variables were estimated from
available items, based on a Stochastic Regression Imputation (SRI)
approach, which improves deterministic regression imputation by im-
puting a value which includes a random error (van Ginkel et al., 2010),
hereby avoiding both bias and overfitting (Enders, 2006). For missing
self-report items, the regression model underlying SRI was based on all
other items from the questionnaire (within the same assessment). For
missing neurofeedback, ZAN-BPD, psychophysiological information,
EWMT, and BMT variables, the regression model underlying SRI was
based on all other conditions available across assessments. We used the
stochastic regression imputation SPSS syntax provided by van Ginkel
et al. (2010). All variables (including original and imputed data) were
entered into repeated-measures: ANOVA with time (T0, T1, and T2) and
condition (if available) as within-subject factors (*p < .05). If
Mauchly's sphericity test was significant, Greenhouse-Geisser correction
was applied to the degrees of freedom.
To limit the risk of false positive results, results from original data
are reported in case they differed from results with imputed data. If
results from original data do not differ from those with imputed data,
the original data without imputation are not reported. We repeated
analyses on measures with a-priori hypotheses (i.e. our primary end-
points: ZAN-BPD and DERS total score, emotion-modulated startle,
resting HRV and amygdala reactivity to BMT and EWMT) with a con-
servative correction for multiple tests (i.e. Bonferroni-correction).
In addition, we ran correlation analyses between amygdala down-
regulation (deltas of amygdala amplitudes/AUCs subtracting the ‘down’
from the ‘view’ condition) and primary endpoints (i.e. emotion-modu-
lated startle [‘view’ minus ‘down’], resting HRV, amygdala activity to
the EWMT [negative > cross contrast] and BMT [all conditions versus
implicit baseline], ZAN-BPD total score and DERS total score at T0 and
T1, respectively). We also ran correlations between down-regulation
success indices (deltas of amygdala down-regulation [run 1 minus run
4], best performance) and changes in emotion-modulated startle,
resting HRV, amygdala activity to the EWMT and BMT, ZAN-BPD total
score and DERS total score using Pearson's r correlation coefficient.
Changes in amygdala reactivity during the EWMT (negative > cross
contrast) and BMT (all conditions versus implicit baseline), emotion-
modulated startle (‘view’ minus ‘down’), resting HRV, ZAN-BPD total
score and DERS total scores were calculated by subtracting means at T1
from T0. Correlation analyses were limited to our primary endpoints.
We did not run correlations with the remaining outcome measures to
avoid an increase in chances of false discovery due to multiple testing.
3. Results
3.1. Amygdala downregulation success
Participants downregulated the amygdala BOLD amplitude, F
(1,23)= 9.40, p= .01, eta2= .30. This effect was driven by a sig-
nificant difference between ‘down’ and ‘view’ at the fourth training run,
t(23)=−2.51, p= .02, d=−0.51 - whereas at the first, t(23)= -.51,
p= .61, second, t(23)= -.77, p= .45, and third, t(23)=−1.71,
p= .10, training run, amygdala BOLD amplitude did not significantly
differ between ‘down’ and ‘view’ conditions (see Fig. 4A)). Interaction
between condition and run was not significant, F (3,69)= .43, p= .73,
eta2= .02, showing that the observed improvement of amygdala
downregulation over time did not pass the significance level.
Statistical analysis did not support the trend for improvement via
training. Similar results were seen for the amygdala AUC: participants
could downregulate the amygdala AUC, F (1,23)= 13.30, p < .01,
eta2= .37, yet this effect was driven by a significant difference between
‘down’ and ‘view’ at the second, t(23)= 2.48, p= .02, d= .50, and
fourth training run, t(23)=−2.76, p= .01, d=−0.56. In the first, t
(23)= -.97, p= .34 and third, t(23)=−1.38, p= .18 training run,
amygdala AUC did not significantly differ between ’down’ and ‘view’
conditions (see Fig. 4B). Interaction between condition and run was not
significant, F (3,69)= .67, p= .57, eta2= .03.
From the amygdala AUC and amplitudes (delta between ‘view’ and
‘down’) we determined the best run (i.e. largest delta) for each parti-
cipant. When considering the AUC, 6–8 participants each showed best
performance during run 2–4, respectively, whereas only two partici-
pants showed best performance at the first run (see Fig. S3). When
Fig. 4. Amygdala amplitude and AUC in the ‘down’ and ‘view’ conditions at each neurofeedback session. A) Participants significantly downregulated the amygdala
amplitude with neurofeedback comparing the ‘down’ with the ‘view’ condition at run 4. B) participants significantly downregulated the amygdala AUC at run 2 and
run 4. Error bars represent standard error of the mean (SEM). AUC= area under the curve.
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considering the amygdala amplitude, best performance was more
equally distributed across runs.
3.2. Verbal report
The main effect of time of the ZAN-BPD total score revealed that
overall BPD symptoms lessened over time, F(2, 46)= 5.13, p= .010
(uncorrected2), eta2= .18. Post hoc paired t-tests showed a significant
reduction from T0 to T1, t(23)= 3.17, p= .004, d= .65, no significant
change from T1 to T2, t(23)= -.62, p= .54, d= -.13, and a significant
reduction from T0 to T2, t(23)= 2.22, p= .036, d= .45 (see Fig. 5A).
A main effect of time of the DERS total score indicated how difficulties
with emotion regulation did change over time, F(2,46)= 3.78, p= .03
(uncorrected2), eta2= .14 (see Fig. 5B). Post hoc paired t-tests showed
a significant reduction from T1 to T2, t(23)= 2.42, p= .025, d= .49
and from T0 to T2, t(23)=−2.40, p= .024, d= .49. Original data
without imputation revealed nonsignificant main effect of time of the
DERS total score, F(2,40)= 2.48, p= .10, eta2= .11.
Explorative analyses showed a significant main effect of time for the
SEK total score, F(2,46)= 5.90, p= .01, eta2 = .20, indicating change
of emotional competence over time (see Fig. 5C). Post hoc paired t-tests
revealed that emotion regulation skills and their efficacy significantly
increased from T1 to T2, t(23)=−2.71, p= .01, d=-.55, and sig-
nificantly increased from T0 to T2, t(23)=−2.73, p= .01, d= -.56.
Overall alexithymia symptoms did not significantly change over time,
as indicated by the TAS-26 total score, F(1.36, 31.22)= 2.76, p= .10,
eta2= .10 (see Fig. 5D)). The subscales ‘Difficulty describing feelings’
and ‘External thinking’ did not significantly change, whereas ‘Identifi-
cation of one's feelings’ did significantly change over time, F
(2,46)= 6.25, p < .01, eta2= .21 (see Table 1). No significant main
effect of time was found for the total score of the ALS and the DSS-21
(see Table 1).
Original data without imputation revealed a nonsignificant main
effect of time for the SEK total score, F(1.59, 27.07)= 3.34, p= .06,
eta2= .16, but a significant main effect of time for the TAS total score,
F(2,36)= 5.33, p= .01, eta2= .27. Post hoc paired t-test of original
TAS total scores revealed a significant reduction from T1 to T2, t
(18)= 2.78, p= .01 and from T1 to T2, t(18)= 2.56, p= .02. Results
of the original TAS subscales can be found in the supplement.
To follow a conservative approach, we further discuss and interpret
the original instead of the imputed data in case they differ from the
imputed data. A detailed perspective of interviewer- and self-assess-
ment results at T0, T1, and T2 can be found in Table 1.
3.3. Everyday experience: EMA
Explorative paired t-tests contrasting T0 and T1 revealed a sig-
nificant reduction of mean negative affect (NA), t(23)= 3.46, p< .01,
d= .70, a significant reduction of mean inner tension, t(23)= 3.27,
p < .01, d= .67, a nonsignificant reduction of mean dissociative
symptoms, t(23)= 1.85, p= .08, d= .38, and a significant increase of
mean emotion regulation control, t(23)=−2.07, p= .05, d= -.42 (see
Fig. 6A). No significant effects were found for mean positive affect (PA),
t(23)= 1.28, p= .21, d= .26. Paired t-tests of the MSSDs revealed a
significant reduction of instability in PA, t(23)= 2.30, p= .03, d= .47,
NA, t(23)= 2.73, p= .01, d= .56, and inner tension, t(23)= 3.41,
p< .01, d= .18 (see Fig. 6B). No significant effects were found for the
instability of dissociative symptomatology, t(23)= 1.71, p= .10,
d= .35. Adherence to prompts was 69.21% (SD = 18.18) at T0 and
63.87% (SD=17.34) at T1, which is satisfactory. There was no sig-
nificant difference in adherence between T0 and T1, t(23)= .16,
p= .12.
3.4. Behavior: emotion regulation test and resting HRV
As hypothesized, patients could downregulate negative emotions
more effectively after training, indexed by a significant decrease of the
emotion-modulated startle in the ‘down’ compared to the ‘view’ con-
dition after training, F(2,46)= 4.23, p= .02, eta2= .16 (un-
corrected2). There was no significant main effect of time, F(2,46)= .90,
p= .42 and condition, F(1,23)= .39, p= .54. The interaction was due
to a significant difference between the ‘down’-‘neutral’ and the ‘view’-
‘neutral’ condition at T1, t(23)=−2.15, p= .04, d=-.44. In T0 and
T2, in contrast, patients did not significantly decrease startle in the
‘down’-‘neutral’ vs ‘view’- ‘neutral’ comparison (see Fig. 7A).
Results from original data revealed similar results, except for the
post hoc paired t-tests of original emotion-modulated startle data:
Emotion-modulated startle was lower in the ‘down’ than the ‘view’
condition at T1, but this effect was only at the trend-level, t
(17)=−2.01, p= .06, d= -.47.
Arousal ratings of the emotion regulation test (‘down’-‘neutral’;
‘view’-‘neutral’ significantly changed over time, corroborated by a sig-
nificant main effect of time, F (2,46)= 18.64, p < .01, eta2= .51. A
significant main effect of condition indicated that overall arousal rat-
ings were significantly lower in the ‘down’-‘neutral’ than in the ‘view’-
‘neutral’ condition, F(1,23)= 3.33, p= .03, eta2= .23. Post hoc t-tests
between the ‘down’ and ‘view’ condition at T0, T1, and T2, respectively,
revealed no significant effects, all ps > .10. Valence ratings of the
emotion regulation test (‘down’-‘neutral;’ ‘view’-‘neutral’) substantially
changed over time, corroborated by the main effect of time, F
(2,46)= 3.22, p= .05, eta2= .16. Interaction of time and condition
was not significant.
Resting HRV did not change over time, F(1.33, 23.870)= 1.27,
p= .23, eta2= .07 (see Fig. 7B).
3.5. Brain responses: EWMT and BMT
EWMT accuracy was not significantly different between conditions
and did not improve, all ps > .10. EWMT reaction times were sig-
nificantly increased in the ‘negative’ versus ‘cross’ condition, F
(2,46)= 3.66, p= .03, eta2= .14, but did not change over time, as
corroborated by a nonsignificant interaction of time and condition,
p > .10. Contrary to our hypothesis, amygdala reactivity did not
change over EWMT sessions, indicated by a nonsignificant interaction
effect, F(2,46)= .87, p= .43. eta2= .04 (see Fig. 8A).
Regarding the BMT, amygdala activity to quickly-presented happy
and fearful faces did not significantly change after neurofeedback, al-
though a decreasing trend could be observed, F (2,46)= 2.74, p= .08,
eta2= 0.11 (see Fig. 8B).
3.6. Correction for multiple testing
We repeated analyses on primary endpoints (ZAN-BP and DERS
total score, emotion-modulated startle, resting HRV, amygdala re-
activity to EWMT and BMT) using a Bonferroni-corrected alpha-level of
p= .008. None of the main effects remain statistically significant with
Bonferroni-correction.
3.7. Correlations between neurofeedback success and outcome measures
There were no significant correlations between amygdala down-
regulation at run 4 and any of the primary endpoints (see supplement
Table S3). Amygdala amplitude down-regulation at run 1 correlated
significantly and positively with resting HRV at T0 (r= .51, p= .01,
N=24; not significant with Bonferroni-correction), and significantly
and negatively with the ZAN-BPD total score at T0 (r= -.45, p= .03,
N=24; not significant with Bonferroni-correction). Changes in down-
regulation of amygdala amplitude and AUC during neurofeedback and
changes in primary endpoints did not significantly correlate (see2 no correction for multiple testing was applied.
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Fig. 5. Diagnostic interview and self-as-
sessment results at T0, T1, and T2. A) BPD
psychopathology significantly (p < .05
uncorrected) improved from T0–T1 and
from T0–T2. B) Difficulties with the
Emotion regulation Scale (DERS) total
score significantly3 reduced from T1–T2
and from T0–T2, indicating that difficul-
ties in emotion regulation decreased over
time. C) Self-assessment of the emotional
competencies (Selbsteinschaetzung Emot-
ionaler Kompetenzen, SEK) total score
significantly increased from T1–T2 and
from T0–T2, showing an increase in emo-
tional competence over time. D) A trend in
reduction of alexithymia was observed,
but did not pass the significance test. Error
bars represent standard error of the mean
(SEM).
Fig. 6. Ecological Momentary Assessment (EMA) data were assessed before (T0) and after (T1) neurofeedback training. A) Mean negative affect (NA) and inner
tension significantly decreased, and perceived control over one's own emotions increased from T0–T1. Perceived control over one's own emotions was assessed with
two items: asking how much participants felt they can control / cannot control their emotions now (see supplement for exact wording). Mean dissociation and
positive affect (PA) did not significantly change from T0–T1. B) Mean squared successive differences (MSSD; i.e., hour-to-hour variability) of PA, NA, and inner
tension significantly decreased from T0–T1, while the hour-to-hour variability of dissociation and perceived control over one's own emotions did not significantly
change from T0–T1. Error bars represent standard error of the mean (SEM).
Fig. 7. A) Mean startle amplitudes in the ‘down’ and ‘view’ condition at each assessment (T0, T1, and T2). Mean amplitudes represent the T-score converted to
difference scores (‘down’ minus ‘neutral’ and ‘view’ minus ‘neutral’). Results indicate a significant reduction of emotion-modulated startle amplitude in the ‘down’
versus ‘view’ condition at T1, but not at T0 or T2. B) Resting HRV did not significantly change over the course of the study. Error bars represent standard error of the
mean (SEM).
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supplement Table S3 for results). Similarly, there were no significant
correlations between participants’ best performance and changes in
measures with a-priori hypotheses (Table S4).
4. Discussion
This is the first study assessing alterations in a variety of emotion
processing and emotion regulation measures after amygdala neuro-
feedback training for BPD. This is an important step towards advancing
neurobiological models and treatment for BPD, using endogenous
neuromodulation with neurofeedback. Our results show that BPD pa-
tients were able to downregulate amygdala activation with neuro-
feedback. BPD psychopathology, emotion dysregulation, and affective
instability improved at several levels of analysis, including self-report,
startle modulation, and experience in everyday life. With regard to our
primary endpoints, effects failed to pass significance level when ap-
plying a conservative correction for multiple tests. Therefore, our re-
sults need to be treated as preliminary and should be replicated by an
independent study.
In line with our hypotheses, we observed changes in the ZAN-BPD
interview, suggesting that subjectively-experienced BPD symptoms
improved over the course of the study. These results are in accordance
with other studies reporting associations of amygdala normalization
and reductions in BPD psychopathology, and are in harmony with the
notion that amygdala response is a critical mechanism of remission with
BPD (Goodman et al., 2014; Schnell and Herpertz, 2007).
In addition, the present results on our EMA analyses indicate that
negative affect and affective instability experienced in daily life re-
duced over time as well. Affective instability in BPD is supposed to arise
from high sensitivity of neural systems involved in the generation of an
emotional state, in combination with a severe emotion regulation def-
icit (Koenigsberg, 2010; Putnam and Silk, 2005). Increased amygdala
activation has been interpreted as impairment in top-down control of
the prefrontal cortex and may therefore contribute to affective in-
stability (Dillon and Pizzagalli, 2007; Herpertz et al., 2018; Schulze
et al., 2016). Amygdala neurofeedback training might be specifically
suited to target the neural mechanisms of affective instability in pre-
cision psychiatry, although more research is needed for corroboration.
On the physiological level, we found an improvement in emotion
regulation after training, evidenced by reduced startle-response, which
suggests that participants improved their ability to regulate negative
emotions. The neural pathway of the emotion-modulated startle in-
volves midbrain neurons, mainly controlled by the central nucleus of
the amygdala (Rosen et al., 1991). Enhanced amygdala activation leads
to enhanced startle response (Davis et al., 1999; Rosen and
Davis, 1988). Given the strong relation between emotional dysregula-
tion, enhanced amygdala activation, and enhanced startle response
(Davis et al., 1999; Rosen and Davis, 1988), our results suggest that
emotion-modulated startle is a sensitive measure for investigating
therapeutic effects of amygdala neuromodulation. Improvements in
emotion regulation, assessed with the emotion-modulated startle,
however, faded to the follow-up test; that is, some training effects did
not persist for 6 weeks. Future studies must gain more stable effects,
such as adding booster sessions or homework between sessions
(Paret et al., 2019).
Contrary to our hypotheses, we did not find significant changes at
the brain level. That is, amygdala response to negative pictures and
facial expressions did not significantly lessen after neurofeedback
training. In addition, no significant changes in resting HRV were ob-
served. A possible explanation could be that these tasks simply do not
measure the mechanisms that are trained with neurofeedback. During
the EWMT and BMT, participants viewed emotional pictures, but were
not explicitly told to regulate their emotions. Rather, these tasks mea-
sure the spontaneous response to negative stimuli. Likewise, resting
HRV is a measure of autonomic flexibility representing the capacity for
spontaneously regulated emotional responses (Appelhans and
Luecken, 2006). In contrast, participants showed improvements in the
emotion regulation test after training. The emotion regulation test ex-
plicitly instructed participants to downregulate negative emotions. In
other words, our treatment might not alter the spontaneous response to
negative emotions. Rather, participants might have acquired new or
already-strengthened existing emotion regulation skills.
With respect to alexithymia, i.e. the difficulty to cognitively process
emotions, our results suggest a reduction in these symptoms after
training. However, we highlight the explorative fashion of this finding
and we stress that only the original data showed significant reductions.
Nonetheless, our results are in line with a recent study showing that
amygdala electrical fingerprint neurofeedback resulted in a larger re-
duction of alexithymia scores compared to a control group
(Keynan et al., 2019). Conversely, neurofeedback studies to increase the
amygdala response showed that the ability to identify or describe one's
own emotions (as indicated by a subscale of the Toronto alexithymia
scale; TAS), was correlated with the effectivity to increase amygdala
activity (Young et al., 2017, 2014; Zotev et al., 2011), which suggests
that individuals with less symptoms of alexithymia might have better
prerequisites to learn increasing their amygdala activity with neuro-
feedback. Together with our results, these studies indicate that the
ability to identify and describe one's own feelings is directly related to
the ability to gain control over the amygdala, however further studies
are needed to fully understand the relation between alexithymia and
amygdala neurofeedback.
Overall, patients were able to downregulate the amygdala BOLD
response with feedback, which is in line with our prior study
(Paret et al., 2016). However, when looking at each run individually,
we could not observe a significant downregulation effect in all four
runs. Rather, the difference between the ‘down’ and ‘view’ condition
descriptively seemed to increase over time (although the interaction of
run and condition did not pass the significance level). In particular,
significant downregulation of the amygdala amplitude was achieved at
the fourth training run and downregulation of the AUC was achieved at
the second and fourth run. This implies that in BPD patients multiple
training runs are necessary to observe amygdala downregulation with
neurofeedback.
In addition, we determined participants’ best performance (i.e. the
run with the largest delta between ‘view’ and ‘down’). Both down-
regulation of the amygdala BOLD response and best performance did
Fig. 8. A) Right amygdala hemodynamic re-
sponse during the Emotional Working Memory
Task (EWMT) for each visit (T0, T1, T2).
Amygdala hemodynamic response was assessed
using fMRI during exposure to negative pictures,
versus pictures depicting a fixation cross (nega-
tive > cross). B) Right amygdala hemodynamic
response during the Backward Masking Task
(BMT) for each visit (T0, T1, and T2). Amygdala
hemodynamic response was assessed using fMRI
during exposure to fearful and happy faces. Error
bars indicate standard error of the mean (SEM).
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not correlate significantly with any of our primary endpoints. Thus,
evidence for a mechanistic relationship between amygdala regulation
and emotion dysregulation is still missing. The lack of significance may
be a function of several causes, including lack of power and technical
issues. For example, the neurofeedback training was optimized to in-
crease absolute training time but was less optimal in terms of quanti-
fying downregulation of the amygdala, as the view condition of each
session was comprised of only five pictures, while the ‘down’ condition
was comprised of 25 pictures. Additionally, shifts of behavior, phy-
siology, and cognition during an emotional response are often loosely
coupled (Bonanno and Keltner, 2004), and as such, a significant cor-
relation is not necessarily observable, particularly in small sample sizes.
Placebo-controlled trials are necessary to corroborate that neurofeed-
back training is indeed causal for improvement in emotion regulation.
4.1. Limitations
Several limitations merit comment. Most importantly, the present
study lacks a control group, so that our results do not allow conclusions
about the specificity and efficacy of neurofeedback training. It is pos-
sible that factors other than the neurofeedback training itself account
for the results. For example, it could be that the motivation to try a new
treatment approach, psychosocial factors or effects of repeated ex-
posure of tasks (i.e. practice effects) led to the observed changes.
Therefore, replication in a randomized controlled trial is necessary. In
addition, we assessed a large number of different outcome measures.
Testing many different outcome measures in a single patient cohort is
the only way to identify potential behavioral targets for a new, tech-
nically-demanding, and cost-intensive technique (such as neurofeed-
back), given the current database and limited financial resources.
Multiple comparisons however bare the risk of false discovery. To
overcome this issue, we repeated statistical tests of primary endpoints
with a conservative correction for multiple tests (i.e. Bonferroni-cor-
rection). No statistical tests survived significance testing with correc-
tion. Notwithstanding such disenchanting outcome, several compar-
isons (e.g. ZAN-BPD, startle response) achieved medium effect sizes.
With appropriate sample size, future studies might replicate this finding
and achieve significant outcomes.
Finally, the fixed order of the EWMT and BMT in the experiment
might induce bias. Both tasks were performed prior to the first scanning
session and immediately after the last neurofeedback training. At the
end of the last scanning session, participants might have been fatigued
and less capable or motivated to concentrate. Similarly, results from the
ZAN-BPD should be interpreted with caution, as EMA assessment was
conducted one week before the ZAN-BPD interview and may have
biased the effect, as interviewers were not blinded to treatment.
4.2. Conclusions
Until now, it has been unclear which aspects of psychopathology and
emotion regulation may change with neurofeedback-aided amygdala
downregulation. The present study provides the first preliminary empirical
basis for informed decision-making in primary outcome measures of larger
clinical trials of amygdala neurofeedback training. We show that general
BPD psychopathology, as well as different aspects of emotion dysregula-
tion, improve after training, although these effects do not remain statis-
tically significant after a conservative correction for multiple tests. If
confirmed by an independent study, our results suggest that the ZAN-BPD,
emotion regulation (assessed with emotion-modulated startle), and EMA
are appropriate measures to quantify these improvements. Future placebo-
controlled trials must confirm that neurofeedback treatment is effective in
improving emotion regulation in those with BPD. Future trials will allow
for the development of new therapy concepts, including neurofeedback
that can be incorporated into clinical practice. In addition, the causal
pathway through amygdala hyperactivation, regarding symptoms of
emotion dysregulation, can also be tested.
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